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ABSTRACT 
Background: Deliberate self-injury (DSI) is significantly associated with 
personality disorder (PD). There are gaps in our knowledge of DSI as an 
indicator of severity of psychopathology, as moderator of outcome and with 
regard to its response to different treatment programs and settings  
Methods: We compare two samples of PD with (n=59) and without (n=64) 
DSI in terms of clinical presentation, response to psychosocial treatment and 
relative outcome when treated with specialist long-term residential and 
community-based programs. We test the assumption that DSI is an 
appropriate indicator for long-term inpatient care by contrasting the outcomes 
(symptom severity and DSI recidivism) of the two DSI sub-groups treated in 
the two different approaches. 
Results: PD with DSI had greater severity of presentation on a number of 
variables (early maternal separation, sexual abuse, Axis-I comorbidities, 
suicidality and inpatient episodes) than PD without DSI. With regard to 
treatment response, we found a significant 3-way interaction between DSI, 
treatment model and outcome at 24-month follow-up. PD with DSI treated in a 
community-based program have significantly greater chances of improving on 
symptom severity and recidivism of self-injurious behavior compared to PD 
with DSI treated in a long-term residential program.  
Conclusions: Although limitations in the study design invite caution in 
interpreting the results, the poor outcome of the inpatient DSI group suggests 
that explicit protocols for the management of DSI in inpatient settings may be 
beneficial and that the clinical indications for long-term inpatient treatment for 
severe and non-severe personality disorder may require updating. 
Keywords: deliberate self-injury, personality disorder, borderline personality 
disorder, treatment outcome, psychosocial treatment, inpatient treatment, 
community-based treatment, empirical study   3 
Introduction and background 
Deliberate self-injury (DSI), the intentional and direct injury of one’s body 
tissue without conscious suicidal intent,  sometimes referred as self-
mutilation, non-suicidal deliberate self-harm and self-wounding [1,2], has an 
approximate prevalence of 4% in the general population [3] with higher rates 
found in adolescents, young adults  
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and in clinical populations [4,5].  Although self-injury is a ubiquitous symptom, 
which can be present across psychiatric diagnostic entities [6], research has 
shown that DSI is significantly associated with personality disorder (PD), in 
particular borderline personality disorder [7,8]. This is not surprising because 
of the function DSI serves in temporarily relieving negative feelings, regulate 
emotional storms, ending dissociative states and trying to influence 
interpersonal transactions [9], all core features of borderline psychopathology. 
Repeated episodes of self-injury are clinically meaningful as they lead to 
serious distress in patients themselves, their relatives and mental health 
professionals, interfere with the ongoing continuation of a therapeutic 
relationship and increase utilization of medical and mental health services. 
  
Despite the extensive literature on the treatment of DSI, some areas of 
enquiry have not been sufficiently explored. For example, while clinical 
evidence suggests that personality disorder with DSI (PDSI) may be a 
particularly difficult-to-treat group and may be more disturbed on several 
areas of psychological functioning than personality disorder without DSI 
(PDnSI) [10], there have been only a handful of studies comparing personality 
disordered patients with and without deliberate self-injury [11]. In particular, 
while severe deliberate self-harm is a common indicator for inpatient 
treatment [12,13], there is no universal agreement regarding the optimal 
setting and treatment model for treating personality disorder with and without 
DSI [14]. With some notable exceptions [15-17], there is a corresponding 
paucity of research comparing the relative effectiveness of different 
therapeutic settings and treatment approaches for the treatment of personality   4 
disorder. There are also gaps in our knowledge regarding the impact that 
presence of DSI in personality disorder patients has on treatment compliance, 
response to specialist treatment and medium-term outcome.  
 
In a previous report we presented evidence that long-term specialist 
residential treatment in a therapeutic community setting had superior 
outcomes for individuals with severe PD than treatment as usual, but was 
significantly less effective compared to a less intense but longer step-down 
program [18]. However, the results showed a considerable variability between 
the treatment responses of individual subjects.  
The aims of this study are to explore the differences between PDSI and 
PDnSI in terms of risk factors and severity of clinical presentation, and to 
reach a better understanding of the role that DSI has in moderating the 
response to specific treatment effects obtained in different settings and 
programs.  To this ends, first, we compare the two groups on a number of risk 
factors and clinical variables, including severity of presentation to test the 
hypothesis that PDSI experienced greater exposure to risk factors and 
suffered from greater levels of psychopathology relative to PDnSI. Second, 
we explore the extent to which DSI influences outcome relative to personality 
disorder without a recent history of self-injurious behavior. Third, we test the 
hypothesis that DSI was an appropriate indicator for inpatient care and 
contrasted the outcomes of DSI groups across residential versus community 
treatment approaches. Fourth, we explore whether the greater number of risk 
factors associated with PDSI account for differences in outcome and 
differential responsiveness to residential and community-based treatment. 
 
Clinical Setting 
The study was carried out at the Cassel Hospital, Richmond, UK. The Cassel 
is a state funded tertiary referral centre renowned for its specialist 
psychosocial approach to personality disorder that offers three treatment 
programs:  
a) A long-term (up to one year) residential model within the therapeutic 
community setting with no planned specialist outpatient continuation 
treatment, which includes a combination of sociotherapy (daily unit meetings,   5 
community meetings, structured activities, co-responsibility planning for the 
running of the therapeutic community and other structured activities), formal 
psychoanalytic psychotherapy (individual and small group) and psychotropic 
medication  when indicated. The program is more fully described in Griffiths 
[19]. 
b) The step-down program, consisting of a short-term (maximum six months) 
inpatient stay (as above), followed by an outpatient/outreach program (see 
below) described in Chiesa [20].  
c) The community-based direct entry program consists of 18-30 months of 
outpatient and community-based treatment, which includes twice-weekly 
group psychotherapy, weekly meetings with a psychosocially trained 
community outreach nurse, regular reviews with a senior psychiatrist, family 
and couple therapy and as required psychotropic medication. The program is 
described in Chiesa et al. [21].  
 
With regard to referral and treatment pathway, patients with severe 
personality disorders who live outside the Greater London area (GLA), who 
are unable to attend the outpatient and community program offered by the 
Cassel for logistic reasons, are admitted the long-term residential program 
and then discharged back to their local general psychiatric services. Patients 
within the GLA are referred specifically to either the step-down program or the 
community-based program according to the referrer indication and 
preference. At the assessment stage a degree of crossover (<5% of all 
referrals) in treatment allocation between step-down and direct-entry may 
occur on clinical grounds. 
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Although the three programs share reliance on the psychosocial and 
psychotherapeutic approaches to personality disorder, there are differences in 
terms of intensity and complexity of implementation, and the implications of 
these differences for DSI patients will be elaborated in the discussion.    6 
Most patients (80%) were admitted to the programs with a history of non-
responsiveness to psychotropic medication, which they were prescribed for 
several years. The aim in all the arms of the study was to rationalize 
psychotropic medication by reducing polypharmacy and withdrawing 
benzodiazepines. We found no differences in the prescription of psychotropic 
compounds amongst the groups and the typical prescription pattern is 
described elsewhere [22]. 
 
For the purposes of this report, patients allocated to the step-down and the 
community-based programs were combined and contrasted with the long-term 
residential group to test the hypothesis that severe DSI should be considered 
as an indicator for long-term residential treatment provision. PDnSI patients 
might find community based treatments more effective, particularly in the light 
of the potential iatrogenic effects on PDnSI patients for being exposed to DSI 
in a residential treatment setting.  
 
Method 
Study sample 
As shown in the study sample flow chart (fig. 1), all consecutively admitted 
patients to the Cassel Hospital therapeutic community for long-term 
residential treatment (n=79) and to the Cassel Hospital community-based 
treatment program (n=121) over a period of 5 and 13 years, respectively, 
were included in the study. Data was available for 70% of the community-
based sample (n=85), with approximately 18%  refusing to consent to 
research participation or to complete baseline measures, and 12% dropping 
out of the study at subsequent stages after intake.  A somewhat higher 
proportion of the long-term residential patients (30%) refused to consent or to 
complete baseline assessments, while 21% dropped out of the study, leaving 
38 patients in the residential sample.  
 
The two groups were well matched on all available demographic, diagnostic 
and clinical variables, but long-term residential patients had significantly 
higher rates of paranoid (x
2
(1)=9.97, p<0.002) and obsessive-compulsive 
(x
2
(1)=4.62, p<0.04) personality disorders.    7 
 
The patients included in the sample were, on average, in their early thirties. 
Two-thirds were female and the majority was white and unemployed. The 
average length of residential treatment was 8.38 (sd=4.37) months for the 
long-term residential sample, after which almost all received various 
outpatient treatments in the location of their original referral. The community 
sample were in receipt of active outpatient treatment 21.10 (sd=9.56) months.  
 
Of the total sample (residential and community-based), 59 patients (48%) 
presented with at least one episode of DSI in the year before intake 
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 (PDSI group), while 64 patients (52%) had no history of DSI in the year prior 
to intake (PDnSI group). DSI was defined as the intentional infliction of injury 
to one’s body tissue without conscious suicidal intent, resulting in body tissue 
damage requiring medical or nursing attention. Patients with suicidal gestures 
without associated DSI (n=14) were included in the PDnSI group. 
 
Measures 
Only diagnostic variables, self-reported symptoms and interview-based 
measures of DSI were assessed in this study.  
The Structured Clinical Interview for DSM-IV [23], applied only at intake into 
treatment, was used to obtain full diagnostic Axis-I & -II profiles.  
 
The Brief Symptom Inventory (BSI) [24] was used as a self-report measure of 
the severity of symptoms.  The BSI consists of forty-five 5-point scales that 
measures patients’ subjective experience of symptoms and yields a highly 
reliable indicator of overall symptom severity, the General Severity Index 
(GSI).  The BSI was completed at baseline, and at 6, 12 and 24 months after 
intake. 
 
A modification of the Suicide and Self-Harm Inventory (SSHI) [25], was used 
to assess self-injury. This is an interview based measure where details of self-  8 
harm (DSI and attempted suicides) episodes over the year prior to the 
assessment are collected and rated using operational definitions for anchor 
points. Non-suicidal self-injury on this measure includes skin cutting and 
scratching, head banging, hitting and burning. The interviewer was required to 
write details of each DSI to be rated blind by a senior psychiatrist. A random 
sample of the interviews was checked against the records of the patients’ 
General Practitioners, who receive details of all medical and psychiatric 
procedures concerning their patients, and a second sample was subjected to 
test-retest reliability checks. This measure was applied at intake, and 12 and 
24 months after intake to cover the 12 months period prior to the assessment 
point. Participants were grouped into non-self-injuring (PDnSI) and self-
injuring (PDSI) groups on the basis of SSHI ratings of presence/absence of 
non-suicidal self injury at intake interviews.  
 
All intake measures were applied after discharge from the residential facility 
for step-down patients in order to minimize possible carry-over effects of the 
inpatient treatments they received on the observed outcomes of the 
community-based treatments and to ensure that that the differences in 
outcome should be attributable to the outpatient treatment.  
 
Statistical analysis 
All analyses were performed using either the Statistical Package for the Social 
Sciences (SPSS) version 18 or STATA/SE version 11. Comparison of the 
PDnSI and PDSI samples on categorical variables were based on Pearson 
chi square statistics or Kendal’s Tau-b statistics for ordered contingency 
tables. On continuous variables, t-test for independent samples with robust 
standard errors was used, except when distributional properties did not permit 
the use of parametric statistics, and then appropriate non-parametric 
equivalent tests were performed.  
In order to examine the extent of overlap in predicting DSI from significant 
demographic, pre-morbid and clinical variables a discriminant function 
analysis was performed, including discriminating variables, which remained 
significant predictors when included in the canonical function and improved 
the percent correctly classified in a jack-knifed classification.    9 
 
The primary outcome measure (BSI-GSI) assessed at regular intervals over a 
two-year period was analyzed using mixed effects linear growth curve models 
[26]. Covariates that could moderate or account for some of the group 
differences based on differences at baseline (paranoid PD and obsessive-
compulsive PD) were included in the models and the results were compared 
with models without the covariates.  None of the covariates we tested yielded 
a significant improvement on any of the models. In addition, the average 
pre/post effect size (Cohen’s d) for GSI was calculated for each sample [27].  
 
To measure the clinical significance of change, outcome was also analyzed 
as a categorical variable by calculating a Reliable Change Index (RCI)
1 for 
BSI-GSI using the formula provided by Jacobson and Truax [28]. A 
Hierarchical Loglinear analysis with backward elimination, which included 
reliable change, deliberate self-injury at intake and treatment program was 
then performed to test the significance of the 3-way interaction between these 
factors.  
 
For effects on rates of self-injury at 12 and 24-month follow-up, two separate 
logistic regressions for binary data (self-injury vs. no self-injury) were used, 
with presence or absence of self-injury at 12 and 24 months as the dependent 
variable and treatment status and self-injury status at intake as predictors.  
 
Results 
DSI and intake variables 
Table 1 outlines differences in socio-demographic, risk factors and clinical 
features between the PDSI and the PDnSI samples. We found no significant 
difference in age, gender, marital status, education, and employment status. 
The PDSI group had significantly higher rates of early separation from the 
primary care-giver (x
2
(1)=4.27, p<0.04, d=0.38), sexual abuse by a blood 
relative (x
2
(1)=6.17, p<0.02, d=0.46), greater exposure to sexual molestation 
                                                 
1 Reliable change takes into account of measurement error according to the formula: 
x2 –x1/ Sdiff, where x1 is the pre-test score and x2 is the post-test score, and Sdiff is the 
standard error of difference between the two test scores. RCI values below 1,96 represent 
changes ascribable to the imprecision of the measurement.   10 
by non-related adults (x
2
(1)=5.12, p<0.03, d=0.42) and, to a marginally 
significant extent, physical abuse (x
2
(1)=3.61, p=0.059, d=0.35), compared to 
the PDnSI group.  
 
With regard to Axis-I disorders, on average PDSI met diagnostic criteria for a 
significantly higher number of psychiatric syndromes than PDnSI (Mann-
Whitney test: Z=-3.27, p<0.01). PDSI had significantly higher rates of 
substance misuse and eating disorders relative to PDnSI (x
2
(1)=5.74, p<0.02, 
d=0.44, and x
2
(1)=5.28, p<0.03, d=0.42, respectively).  
 
As expected, a diagnosis of borderline personality disorder was significantly 
associated with DSI (x
2
(1)=6.39, p<0.01, d=0.47): 76.3% of patients with a 
history of self-injury in the year prior to the rating met criteria for BPD, 
compared to 54.7% of patients with no record of self-injury. No other Axis-II 
disorder showed significant differences in DSI. 
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Self-injury appeared to be significantly associated with suicide gestures in the 
year prior to intake assessment (x
2
(1)=6.06, p<0.01, d=0.46). Patients with DSI 
had spent a significantly higher number of days as a psychiatric inpatient in 
the year prior to the assessment than patients with no DSI (Z=-2.85, p<0.004). 
No differences were found between the groups in the severity of other 
presentation variables, such as the general severity index of the BSI (Z=-0.59, 
p=0.56 NS) and the average number of personality disorder for which each 
patient met diagnostic criteria (Z=-0.61, p=0.54 NS). 
 
In order to examine if all the significant clinical history and diagnostic variables 
independently predicted PDSI we performed a discriminant analysis with 
maternal separation, incest, sexual molestation, BPD diagnosis as 
independent variables (canonical r=0.39, Wilks’ lambda=.85,  F(4, 118)=5.24, 
p<0.0006). Interestingly all independent variables remained significant 
predictors of DSI (pooled within group correlations with canonical discriminant   11 
function: sexual molestation=0.55, p<0.001; incest=0.54, p<0.001; BPD=0.53, 
p<0.001 and early separation=0.41, p<0.001). With these discriminator 
variables, 74% of the original grouped cases could be correctly classified 
using a cross-validation method when each case is classified by the functions 
derived from all cases other than that case. Including number of PD diagnosis 
and suicide attempts as discriminators did not improve the discrimination. 
 
With regard to duration of psychosocial treatment, the mean length of 
treatment of PDnSI and PDSI, in both programs, was 18.9 months (sd=10.2) 
and 15.2 months (sd=9.9), respectively (Z=-1.86, p=0.063). However, dropout 
by ten months was significantly lower in patients treated in the community-
based program com- 
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pared to long-term residential patients (11.9% v 50.0%, respectively; 
x
2
(1)=20.96, p<0.0001). Specifically, PDSI patients treated in the community-
based program had considerably lower rates of attrition compared to the 
residential PDSI subjects (19.5% and 64.7%, respectively). 
 
Outcome 
Mean GSI scores for both DSI and non-DSI groups are shown in Table 2. In 
the mixed effects model applied to the data both participant intercept and 
slope were allowed to vary randomly. The model with time, self-injury status at 
intake and the interaction of these factors as predictors provided a highly 
significant model overall (Wald x
2
(3)=41.2, p<0.0001).  The coefficient for the 
slope for the time variable was highly significant (β(time)=-0.21, 95% CI= -0.28 - 
-0.13 , z=5.41,  p<0.0001). The coefficient for the differences between the 
mean levels of the two groups (intercepts) was not significant (β(DSI)=-0.13, 
95% CI= -0.24 - 0.51, z=0.69, NS), but the coefficient for the difference 
between the slopes of the groups was significant (β(time x DSI)=0.17, 95% CI= 
0.05 - 0.28, z=2.75, p<0.006).   These results suggest that although   12 
surprisingly there was no overall difference in GSI scores between the PDnSI 
and the PDSI groups, the latter group improved at a faster rate.   
Further, the difference in the likelihood of reliable change in GSI scores 
favored the PDnSI group with the rates of improvement, no change and 
deterioration in PDnSI versus PDSI observed to be  65.6% v 51.8%, 26.6% v 
28.6% and 7.8% v 19.6%, respectively (Kendall’s tau-b=-0.16, p=0.067). 
 
Treatment model, outcome and DSI 
In the next phase of the analysis, we explored the hypothesis that long-term 
residential intensive treatment was particularly indicated for patients who were 
self-injuring at the time of referral while a community oriented, outpatient 
treatment model suited non-self-injuring patients better. To test the hypothesis 
we repeated the mixed-effects regression with our primary outcome variable 
(GSI scores) as dependent variable, adding treatment program (community-
based and long-term residential) to time and self-injury status at intake as 
predictors. This model was highly significant overall (Wald x
2
(7)=76.44, 
p<0.0001).  The coefficient for the slope for the time variable was again highly 
significant (β(time)= -0.14, 95% CI= -0.21 - -0.08, Z=4.1, p<0.0001). The 
coefficient for the difference between the slopes of the two types of treatment 
models was significant (β(model x time)= -0.13, 95% CI: -0.25 - -0.01, Z=2.16, 
p<0.03), suggesting that the rate of decline of GSI scores in the community-
based program was steeper overall than in the long-term residential program. 
A large difference emerged when the 3-way interaction of symptom decline 
slopes were contrasted between the two treatment modalities separately for 
the PDnSI and PDSI groups (β(DSI x model x time)= 0.30, 95% CI= 0.12 - 0.47, 
Z=3.3, p<0.001).    
As Figure 1 illustrates, while the GSI scores of the PDnSI group improved in 
both treatment modalities, the PDSI group only showed marked change in the 
community-based treatment. In fact, the PDSI group treated in the long-term 
residential program did not show changes in GSI over the two-year period 
(d=0.05, 95% CI: -0.11 - 0.22), while PDnSI showed highly significant 
improvement with a large pre-post effect size (d=1.88, 95% CI: 1.75 - 2.01). 
The pre-post effect sizes for the PDSI and PDnSI groups treated in the 
community-based psychosocial program improved significantly with moderate   13 
to small effect sizes (d=0.33, 95% CI: 0.03 - 0.63, and d=0.53, 95% CI: 0.36 - 
0.69, respectively).  Controlling for variables significantly associated with DSI 
status, maternal separa- 
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tion, sexual abuse, substance misuse, number of axis-I diagnoses, borderline 
personality disorder status, eating disorder status, time in inpatient services, 
and suicide attempts did not affect the strength of the 3-way interaction .  
 
In order to ensure that the effect was associated with community-based 
versus residential treatment, we excluded those community-based patients 
who had previous residential treatment at the Cassel and repeated the mixed-
effects regressions. The results mirrored the findings reported above. There 
remained a significant 3-way interaction of symptom decline slopes contrasted 
between the two treatment modalities separately for the PDnSI and PDSI 
groups (β(DSI x model  x time)= 0.26, 95% CI= 0.03 - 0.50, Z=2.2, p<0.03). Further, 
we examined if the two community-based treatment groups (step-down and 
direct-entry) differed in terms of the impact of DSI on treatment response. The 
mixed-effects regression model (Wald x
2
(7)=47.40, p<0.0001) was significant, 
but only the effect of time made a significant contribution to the model (β(time)= 
-0.16, 95% CI= -0.25 - -0.08, Z=3.73, p<0.0001). The type of community 
treatment (step-down or direct-entry) had no main effect (β(model)= 0.16, 95% 
CI= -0.37 - 0.70, Z=0.59, NS) nor did it significantly interact with rate of GSI 
decline (β(model x time)= 0.05, 95% CI: -0.09 - 0.18, Z=0.71, NS) or DSI status 
(β(DSI x model)= 0.29, 95% CI= -0.52 - 1.10, Z=0.70, NS) or the combination of 
the two (β(DSI x model  x time)= 0.01, 95% CI= -0.22 - 0.23, Z=0.09, NS).  
 
Table 3 shows rates of reliable change in PDSI and PDnSI treated in the 
community-based program and the long-term residential program. Both 
community-based PDSI and community-based PDnSI similar high rates of in 
reliable change at the 24-month assessment (n=23, 59.0% and n=25, 58.1%, 
respectively). However, rates of reliable change in the residential sample   14 
diverged markedly, with PDSI showing only modest rates of reliable change 
(n=6, 35.3%) and PDnSI achieving high rates of improvement (n=17, 81.0%). 
The hierarchical loglinear analysis revealed a significant 3-way interaction 
between reliable change, treatment program and deliberate self-injury status 
(Likelihood Ratio x
2
(1)=6.12, p<0.02). Thus, contrary to prediction, PDSI had a 
better chance of achieving reliable change when treated in the community-
based program (59% vs. 35%, OR=2.64, 95% CI: 0.81 - 8.59), while PDnSI 
were more likely to show reliable symptomatic improvement when treated in 
the long-term inpatient program (81% vs. 58%, OR=3.06, 95% CI: 0.88 - 
10.64). 
 
Figure 3 illustrates the percentages of patients in the community-based and 
long-term residential samples with and without DSI at intake, 12 and 24-
month follow-up. We found that DSI was significantly reduced for patients 
treated in the community-based model (Cochran’s Q=18.07, p<0.001). 
However, for the long-term residential sample a marked deterioration between 
intake and 12 months was followed by a return to DSI intake level at 24-
months (Cochran’s Q=8.77, p<0.01). Two separate logistic regression 
analyses showed that belonging to the community-based program 
significantly predicted lower DSI at 12 and 24 months compared to long-term 
residential treatment (B(model)=-1.66, SE=0.50, p<0.001, and B(model)=-1.40, 
SE=0.50, p<0.005, respectively). The odds for subjects treated in the 
community-based model of not self-mutilating were 5.24 (95%CI 1.97 - 13.89) 
at 12 months, and 4.04 (95%CI 1.51 – 10.87) at 24 months relative to patients 
treated in the long-term residential program.  
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Discussion 
The previously reported finding that personality disorder with DSI presented 
with greater severity of risk factors, clinical presentation and associated co-
morbidities [29] has been confirmed in our sample. PDSI had higher incidence 
of substance misuse, met a higher number of diagnostic criteria for psychiatric 
syndromes, spent more time in acute psychiatric inpatient services, had   15 
higher incidence of attempted suicide and suffered from a significantly greater 
disruption of early attachment relationships compared to PD with no recent 
history of DSI. It is interesting to note that, despite the greater severity of the 
DSI group, there were no differences in self-report symptom distress ratings 
between PDSI and PDnSI. 
 
Contrary to our initial hypothesis, we found that PDSI did significantly worse 
than patients with less severe psychopathology when treated in the long-term 
residential therapeutic program, in terms of reduction of severity of psychiatric 
morbidity, treatment compliance and deliberate self-harm episodes at 2 years 
following intake. Less severe patients had significant benefits from admission, 
showing the largest size of the effect compared to the other sub-groups 
although the difference between community and residential treatment 
outcomes was not statistically significant for the non-DSI group. Controlling for 
the observed characteristics where we found the DSI group to be different 
from the non-DSI group, did not impact on the significance of this 3-way 
interaction raising an intriguing question as to the possible reasons for the 
difference.  
 
Our findings tally with a recent randomized study that showed no difference in 
medium-term outcome on several clinical dimensions in personality disorder 
randomly allocated to either a day-patient psychotherapy program or to out 
patient psychotherapy [17]. The authors further reported that there was no 
indication that the more intensive program (day care) was more effective for 
the most poorly functioning patients.  
 
It is understandable that clinicians might intuitively expect residential 
treatment with near constant supervision, multi-faceted treatment and 
constant peer support from patients, to be both a safer and a more effective 
and appropriate option for DSI patients. Yet, the opposite appears to be the 
case. A primarily community-based, outpatient model with briefer periods of 
admission and without extensive supervision outside of individual and group 
therapy appears to be more effective for these patients.  
   16 
Over the years, a number of authors have questioned the effectiveness of 
long-term hospital admission for severe personality disorder [30-32]. An 
earlier retrospective study carried out at the Cassel Hospital in the 1980’s 
found that ‘neurotic’ individuals had better outcomes than more disturbed 
patients who suffered from ‘borderline’ disorders [33]. It is possible that 
changes in the in-patient therapeutic program did not keep pace with change 
in hospital clientele, which shifted from a mainly chronically neurotic group of 
mild to moderate severity to a borderline group of greater severity of 
presentation. The intensity in terms of treatment inputs, the overall complexity 
of a highly structured hospital milieu with its demands for ‘healthy’ functioning 
and sharing of responsibilities for running the program, the emotionally 
charged atmosphere and the intense interpersonal relationships of the 
therapeutic community setting contribute to the worsening of the emotional 
dysregulation that a sub-group of these patients present with. However, it 
should be noted that controlling for borderline status in this sample did not 
remove the difference in the outcome of the DSI group between the two 
therapeutic settings. Resorting to deliberate self-injury appears to carry 
specific significance in relation to treatment readiness, which may not be quite 
overlapping with the diagnosis of BPD according to DSM-IV criteria.  
 
DSI is a dysfunctional means to obtain relief from negative inner feelings and 
experiences [34] and from strong aversive inner tension [35]. It is a way to 
regulate emotional storms, ending dissociative states and trying to influence 
interpersonal transactions [9]. One or other of these processes appear to 
undermine the possibility of a patient with DSI engaging with the therapeutic 
milieu of the residential unit. Perhaps being able to obtain relief from inner 
tension by DSI decreases patient motivation to engage in the sometimes-
stressful therapeutic environment of the hospital.  
 
It should also be remembered that part of the effect arises out of the 
exceptionally effective way in which non-DSI patients responded to residential 
treatment. It is likely that in the absence of DSI, these patients received a very 
valuable input and were able to take full advantage of the intensity of the 
program and of the opportunities presented by the many therapeutic inputs   17 
available to them.  Perhaps, DSI patients experienced more intensely the 
insidious pressure of sub-group cultures, that occasionally can foster self-
harm as a prized currency of expression, communication and gratification and 
the concomitant process of ‘social contagion’ [36].  
 
It is likely that the combination of residential setting with a non-DSI focused 
protocol creates problems for DSI patients, as some other residential 
treatment programs reported favorable outcomes. For example, dialectical 
behavior therapy applied in an inpatient setting resulted in better retention 
rates and greater reductions of  
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self-harming behaviors compared with treatment as usual, especially among 
those with a history of frequent self-mutilation [37]. In any case, if confirmed 
by further investigations, the poor outcome of the DSI group in this residential 
unit raises questions concerning the manner in which DSI may be handled in 
residential programs without explicit protocols for DSI. In the meantime we 
may need to update the clinical indications for long-term inpatient treatment 
for severe (with DSI) and non-severe (non-DSI) personality disorder. 
 
The community-based program obtained significant treatment effects with 
both PDSI and PDnSI, although the effects for PDnSI were smaller than those 
found in PDnSI treated in the residential model. For patients allocated to the 
community-based program DSI, and other severity features, appear not to be 
a negative predictor of outcome and not to affect the medium-term prognosis 
in terms of both psychiatric morbidity and DSI. Reductions in deliberate self-
harm observed at 24-months follow-up are clinically relevant as they appear 
to be associated with reductions in rates of re-admissions to hospital, overall 
service utilization and suicide attempts [18,38].  
 
It is possible that a non-residential, community-based team can respond more 
flexibly to DSI, take into account the multiple motives and functions that DSI 
can serve across, and within, patients in different stages of treatment.   18 
Contrary to a residential context in which sanctioning, limit setting and 
contracting is more central, tolerance, containment and working through is 
more readily implemented in an outpatient treatment context where emotional 
expression of often-intense anger and use of primitive defenses such as 
splitting and projective identification can be contained, as it impinges less on 
other clients [10]. The repeated experience of being contained and 
understood by a treatment team we may anticipate to gradually reduce the 
malevolent self-object representations present in these patients [39,40]. 
Perhaps equally important, the opportunity to organize attachment 
representations frees the attachment system and generates an appropriate 
sense of belonging to a benign and accepting social group both in therapy 
and in the community. The creation of bonds, perhaps more than any other 
process, has the potential to lift the patients from a sense of emptiness, 
loneliness, depression and despair. The shift in the inner experience and 
mentalizing capacities that develop in the course of any treatment and the 
integration of unwanted emotional experiences reduces the negatively 
reinforced strategy for coping with stressful emotional arousal, which is one of 
the reason for resorting to DSI [35,41].  
 
The potential for both negative and positive therapeutic effects with this 
patient group underscores the importance of gathering empirical data that 
might aid the appropriate treatment of DSI across settings and help orientate 
clinicians to modify current, even potentially iatrogenic, treatment strategies in 
programs that have sub-optimal outcomes on patients with this distressing 
and repetitive behavior. Some authors had been calling for distinct diagnostic 
status for sometime, and deliberate self-injury merited the status of a distinct 
and separate disorder in DSM-IV [42]. The above observations are partially 
consistent with this view, suggesting that DSI is a useful indicator for 
modifying treatment protocols. 
 
Several limitations are present that need to be borne in mind when 
interpreting the study results. We compare samples that were not subjected to 
randomization; hence, the possibility of sampling selection bias cannot be 
ruled out. Some of the patients in the community-based group had short   19 
residential treatment experiences prior to entering the program, so the 
comparison is less clear than we might have hoped. Nevertheless, excluding 
all patients with prior exposure to residential treatment did not substantially 
affect the results. In any event, the study needs replication with larger number 
of patients in each group. In addition, generalizability to other inpatient setting 
is limited given the specialist nature of the inpatient unit where the study took 
place. Other studies of inpatient psychotherapy using a different approach 
might have yielded different results, so the findings should not be generalized 
beyond interventions based on therapeutic community principles [43] without 
an explicit DSI protocol.     20 
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Table 1 
Variable  PDSI (n=59) 
mean (SD) range 
PDnSI (n=64) 
Mean (SD) range 
   Z,           sig 
Age  32.6 (7.0) 19-64  35.1 (9.8) 20-60  -1.16,     0.25 
Number PD diagnosis  3.3 (1.8) 1-8  3.1 (1.4) 1-7  -0.61,      0.54 
Number Axis-I diagnosis  2.30 (1.0) 0-4  1.69 (0.80) 0-3  -3.27,     0.01 
BSI General Severity Index  2.12 (0.80) 0.27-3.57  1.94 (0.74) 0.64-3.43  -0.59,      0.56 
Length previous hospitalization 
(days)            
55.3 (87.3) 0-365  41.8 (80.2) 0-250  -2.85,      0.004 
Length of treatment (months)  15.2 (9.9) 0.63-37.73  18.9 (10.2) 2.1-42.0  -1.86,      0.06 
   N (%)  N (%)  Chi-square, sig 
DSM-IV diagnosis, Axis-I 
            Any mood disorder 
            Any anxiety disorder 
            Any substance misuse 
            Any eating disorder 
 
41 (69.0) 
40 (67.8) 
30 (50.8) 
22 (37.2) 
 
38 (59.4) 
40 (62.5) 
19 (29.7) 
12 (18.8) 
 
1.37,       0.24 
0.38,       0.54 
5.74,       0.02 
5.28,       0.03 
DSM-IV diagnosis, Axis-II  
            Paranoid 
            Schizotypal 
            Borderline 
            Antisocial 
            Avoidant 
            Obsessive-Compulsive 
            Dependent 
 
18 (30.5) 
9 (15.3) 
45 (76.3) 
2(3.4) 
27(45.8) 
16 (27.1) 
21 (35.6) 
 
25 (39.1) 
7 (10.9) 
35(54.7) 
4(6.3) 
32 (50.0) 
14 (21.9) 
23 (35.9) 
 
0.99,      0.32 
0.51,      0.48 
6.39,      0.01 
0.54      0.46 
0.22,      0.64 
0.46,      0.50 
0.02,      0.97 
Maternal separation  23(39.0)  14(22.0)  4.27,      0.04 
Incest  23(39.0)  12 (18.8)  6.17,      0.02 
Sexual molestation  23 (39.0)  13 (20.3)  5.12,      0.03 
Rape  13 (22.0)  8 (12.5)  1.97,      0.16 
Physical abuse  35 (59.3)  27 (42.2)  3.61,      0.06 
Suicide attempts  26 (52.0)  16 (28.5)  6.06,      0.01   25 
Table 2 Means and standard deviations for BSI general severity index in the 
PDSI and PDnSI samples 
 
  PDSI (n=59) 
Mean (sd) 
PDnSI (n=64) 
Mean (sd) 
t, sig 
GSI intake  2.12 (0.82)  1.94 (0.74)  -1.31, 0.19  
GSI 6 months  1.96 (0.85)  1.75 (0.71)  -1.51, 0.13 
GSI 12 months  1.74 (0.98)  1.48 (0.79)  -1.58, 0.12 
GSI 24 months  1.77 (0.96)  1.43 (0.75)  -2.15, 0.03 
 
Mixed effects model (β(time)= -0.14, 95% CI= -0.21 - -0.08, Z=4.1, p<0.0001) 
                               (β(model x time)= -0.13, 95% CI: -0.25 - -0.01, Z=2.16, p<0.03) 
           (β(DSI x model  x time)= 0.30, 95% CI= 0.12 - 0.47, Z=3.3, p<0.001)   26 
Table 3 Difference in rates of GSI Reliable Change (GSI-RC) at 24-month 
follow-up in the PDSI and PDnSI samples treated in the community-based 
and long-term residential programs 
 
 
Treatment 
model  DSI status 
GSI  
No reliable change 
N (%) 
GSI  
Reliable change 
N (%) 
 
Community 
 
PDSI  16 (41.0)  23 (59.0) 
 
 
 
PDnSI  18 (41.9)  25 (58.1) 
 
Residential 
 
PDSI  11 (64.7)  6 (35.3) 
   
PDnSI  4 (19.0)  17 (81.0) 
 
PDSI personality disorder with deliberate self-injury 
PDnSI personality disorder with no deliberate self-injury 
3-way interaction (Treatment model * DSI status * GSI-RC) Likelihood Ratio x
2
(1) =6.11, 
p<0.01 
 
 
 
 
 
 